
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Dompe Farmaceutici
Deal Size : Undisclosed
Deal Type : Collaboration
Eurofins Discovery Extends AI-powered Integrated Drug Discovery Collaboration
Details : The collaboration aims to combine strengths of Eurofins Discovery’s DiscoveryOne comprehensive Integrated Drug Discovery capabilities with Dompé’s powerful supercomputing AI platform.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 10, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Dompe Farmaceutici
Deal Size : Undisclosed
Deal Type : Collaboration

Eurofins Discovery Collaborating with Invasight on Cancer Therapies
Details : Under the collaboration, Invasight is teaming with Eurofins Discovery's DiscoveryOne™, an integrated drug discovery platform, advancing first-in-class, small molecule, protein-protein interaction antagonists (PPIAs) against a protein that causes cancer...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 14, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Amphilix
Deal Size : Undisclosed
Deal Type : Collaboration
Eurofins Discovery Collaborates with Swiss Biotech Amphilix
Details : Amphilix AG will take advantage of Eurofins Discovery's DiscoveryOne™ offering, an integrated drug discovery platform providing expert support to progress programs to preclinical development and beyond.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
November 02, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Amphilix
Deal Size : Undisclosed
Deal Type : Collaboration
